Schall Thomas J. insider trades
Schall Thomas J. has filed 13 Form 4s with the SEC that we hold, for Immuneering Corp (IMRX) (Director) and CCXI (President and CEO, Director). Across all of them we count 4 purchases worth $232.7K and 1 sale worth $6.5M reported on Form 4. In the last 12 months: 1 purchase ($101.1K) and 0 sales ($0). The largest single trade was a sale of 130,000 shares of CCXI worth $6.5M, dated 2022-08-04. The first filing on our record is dated 2021-12-03 and the latest 2026-06-11.
Immuneering Corp (IMRX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-03-22 | P, purchase reported on Form 4 | 2,900 | $7.4K | 2024-03-25 |
| 2025-06-17 | P, purchase reported on Form 4 | 40,485 | $89.5K | 2025-06-18 |
| 2025-06-27 | P, purchase reported on Form 4 | 9,500 | $34.8K | 2025-06-30 |
| 2026-01-15 | P, purchase reported on Form 4 | 21,645 | $101.1K | 2026-01-20 |
CCXI (CCXI)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-08-04 | S, sale reported on Form 4 | 130,000 | $6.5M | 2022-08-08 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1423084) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms